ISSN: 2042-6305
Journal Home
Journal Guideline
Journal of Comparative Effectiveness Research Q2 Unclaimed
Journal of Comparative Effectiveness Research is a journal indexed in SJR in Health Policy with an H index of 39. It has a price of 2100 €. It has an SJR impact factor of 0,708 and it has a best quartile of Q2. It has an SJR impact factor of 0,708.
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -


2100 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,708
SJR Impact factor39
H Index95
Total Docs (Last Year)359
Total Docs (3 years)2502
Total Refs731
Total Cites (3 years)331
Citable Docs (3 years)2.17
Cites/Doc (2 years)26.34
Ref/DocOther journals with similar parameters
Digital Health Q2
Chronic Illness Q2
International Journal for Quality in Health Care Q2
International Journal of Technology Assessment in Health Care Q2
Journal of Medical Screening Q2
Compare this journals
Aims and Scope
Best articles by citations
Cost-effectiveness thresholds in the USA: are they coming? Are they already here?
View moreA comparison of outcomes for early oropharyngeal cancers treated with single-modality surgery versus radiotherapy
View moreIntroducing Volume 8 of the Journal of Comparative Effectiveness Research
View moreComparison of conservative treatment with appendectomy for acute uncomplicated pediatric appendicitis: a meta-analysis
View moreWillingness to pay for medical treatments in chronic diseases: a multicountry survey of patients and physicians
View moreComparative outcome of induced labor by intracervical Foley catheter with misoprostol versus misoprostol alone
View moreComparing twice- versus four-times daily insulin in mothers with gestational diabetes in Pakistan and its implications
View moreAnalysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction
View moreTying comparative effectiveness information to decision-making and the future of comparative effectiveness research designs: the case for antipsychotic drugs
View moreComparative effectiveness and patient-centered outcomes research: enhancing uptake and use by patients, clinicians and payers
View moreComparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System
View moreUsing comparative effectiveness research to remedy health disparities
View moreRiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma
View moreComparative effectiveness of different angiotensin-converting enzyme inhibitors on the risk of hospitalization in patients with heart failure
View moreImproved clinical, functional and work outcomes in spondyloarthritides during real-life adalimumab treatment in central-eastern Europe
View moreComparative effectiveness of efavirenz-based antiretroviral regimens in resource-limited settings
View moreWhy are patients uncertain about the human papillomavirus vaccine's effectiveness?
View moreComparative effectiveness of renin-angiotensin system inhibitors in hypertension
View moreContinuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease
View morePatient and clinician views on comparative effectiveness research and engagement in research
View moreComparative effectiveness of surgery versus antibiotics in acute appendicitis: a systematic review
View moreReporting and analyses of sex/gender and race/ethnicity in randomized controlled trials of interventions published in the highest-ranking anesthesiology journals
View moreStatin prescribing among hypertensive patients in southwest Nigeria: findings and implications for the future
View moreComparative effectiveness of transurethral resection of bladder tumors and office fulguration for recurrent bladder tumors
View more
Comments